ARCHIVES

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

This article is from The Cancer Letter archive.

Vol. 01 No. 01 | December 21, 1973

Download PDF Visit The Full Archive

Related Articles

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Digital Immunoassay PSA Test May Predict Cancer Recurrence

October 28, 2011